Business
Study Finds Wegovy Reduces COVID-19 Death Risk by One-Third - Neuroscience News
A new trial reveals that weekly injections of the weight-loss drug Wegovy (semaglutide) lowered the risk of death from COVID-19 by about a third and reduced overall mortality by 19%.
By: Neurosciencenews.com
- Oct 07 2024
- 0
- 0 Views
Summary: A new trial reveals that weekly injections of the weight-loss drug Wegovy (semaglutide) lowered the risk of death from COVID-19 by about a third and reduced overall mortality by 19%.
The st… [+6283 chars]